Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 642

1.

Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.

Demircin G, Oner A, Erdoğan O, Delibaş A, Baysun S, Bülbül M, Bek K, Oksal A.

Ren Fail. 2008;30(6):603-9. doi: 10.1080/08860220802132171.

PMID:
18661410
2.
3.

[Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].

Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.

Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:19-25. Serbian.

PMID:
12583309
4.

Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.

Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.

Am J Med. 2006 Apr;119(4):355.e25-33.

PMID:
16564783
5.

Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Bogdanović R, Nikolić V, Pasić S, Dimitrijević J, Lipkovska-Marković J, Erić-Marinković J, Ognjanović M, Minić A, Stajić N.

Pediatr Nephrol. 2004 Jan;19(1):36-44. Epub 2003 Nov 22.

PMID:
14634858
6.

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.

Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.

Arthritis Rheum. 2004 Dec;50(12):3934-40.

7.

Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.

Al Arfaj AS, Khalil N, Al Saleh S.

Rheumatol Int. 2009 Jul;29(9):1057-67. doi: 10.1007/s00296-009-0905-8. Epub 2009 Apr 21.

PMID:
19381639
8.

Clinical and prognostic value of serial renal biopsies in lupus nephritis.

Moroni G, Pasquali S, Quaglini S, Banfi G, Casanova S, Maccario M, Zucchelli P, Ponticelli C.

Am J Kidney Dis. 1999 Sep;34(3):530-9.

PMID:
10469865
9.

EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.

Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P.

Ann Rheum Dis. 2004 May;63(5):525-9.

10.

Retrospective analysis of the renal outcome of pediatric lupus nephritis.

Wang LC, Yang YH, Lu MY, Chiang BL.

Clin Rheumatol. 2004 Aug;23(4):318-23. Epub 2004 Jun 2.

PMID:
15293092
11.

The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.

Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B.

Rheumatology (Oxford). 2008 Mar;47(3):311-4. doi: 10.1093/rheumatology/kem365. Epub 2008 Jan 19.

PMID:
18204087
12.

The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.

Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.

J Med Assoc Thai. 1999 Nov;82 Suppl 1:S104-10.

PMID:
10730528
13.

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.

Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.

Arthritis Rheum. 2004 Aug;50(8):2559-68.

14.

Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.

Das U, Dakshina Murty KV, Prasad N, Prayag A.

Saudi J Kidney Dis Transpl. 2010 Mar;21(2):372-8.

15.

Prognostic factors in diffuse proliferative lupus nephritis.

Abraham MA, Korula A, Jayakrishnan K, John GT, Thomas PP, Jacob CK.

J Assoc Physicians India. 1999 Sep;47(9):862-5.

PMID:
10778652
16.

Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.

Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.

Clin Nephrol. 1994 Aug;42(2):71-8.

PMID:
7955581
17.

Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine.

de Glas-Vos JW, Krediet RT, Weening JJ, Arisz L.

Neth J Med. 1995 Jan;46(1):4-14.

PMID:
7877712
18.

The very long-term prognosis and complications of lupus nephritis and its treatment.

Bono L, Cameron JS, Hicks JA.

QJM. 1999 Apr;92(4):211-8.

PMID:
10396609
19.

Prognostic factors of diffuse proliferative lupus nephritis.

Lim CS, Chin HJ, Jung YC, Kim YS, Ahn C, Han JS, Kim S, Lee JS.

Clin Nephrol. 1999 Sep;52(3):139-47.

PMID:
10499308
20.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Pando J, Steinberg AD, Gourley MF, Klippel JH, Balow JE, Boumpas DT.

Arthritis Rheum. 2002 Apr;46(4):995-1002.

PMID:
11953977

Supplemental Content

Support Center